T
Telix Pharmaceuticals
Biotech & Life Sciences · Melbourne, Australia · Founded 2015 · IPO 2017 Unicorn
Global footprint
Where Telix Pharmaceuticals has talent and traffic
team presence
across markets
Patent intelligence
$1M patent portfolio · 11 active families
Where Telix Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Telix Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Telix Pharmaceuticals's 12 investments and acquisitions.
Every disclosed deal where Telix Pharmaceuticals appeared as a backer or acquirer, 2018–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
12 deals across Telix Pharmaceuticals's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Telix Pharmaceuticals's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Telix Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Telix Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Telix Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.